Dexcom (DXCM) Change in Acquisitions & Divestments (2010 - 2026)

Dexcom (DXCM) has reported Change in Acquisitions & Divestments for 17 consecutive years, with $525.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 17.68% year-over-year to $525.8 million in Q2 2026; TTM through Jun 2026 was $1.9 billion, a 19.57% decrease from a year earlier, with the FY2025 full-year figure at $2.2 billion, down 23.36% from the prior year.
• Change in Acquisitions & Divestments was $525.8 million for Q2 2026 at Dexcom, up from $468.2 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $1.1 billion in Q1 2024 and troughed at $241.8 million in Q1 2022.
• A 5-year average of $614.4 million and a median of $634.6 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments sank 69.39% in 2022 and surged 188.5% in 2023, its largest moves.
• Over 5 years, Change in Acquisitions & Divestments stood at $740.0 million in 2022, then slipped by 2.84% to $719.0 million in 2023, then slumped by 43.64% to $405.2 million in 2024, then advanced by 1.09% to $409.6 million in 2025, then gained by 28.37% to $525.8 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $525.8 million (Q2 2026), $468.2 million (Q1 2026), and $409.6 million (Q4 2025), per Business Quant data.